Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) was the target of unusually large options trading activity on Wednesday. Investors bought 20,867 call options on the stock. This represents an increase of approximately 50% compared to the typical daily volume of 13,918 call options.

Insiders Place Their Bets

In other news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Several institutional investors and hedge funds have recently bought and sold shares of the business. KBC Group NV raised its position in Teladoc Health by 72.3% in the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after purchasing an additional 3,714 shares during the last quarter. Westside Investment Management Inc. raised its position in Teladoc Health by 43.8% during the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after buying an additional 2,800 shares during the last quarter. Nisa Investment Advisors LLC raised its position in Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock worth $3,874,000 after buying an additional 424,180 shares during the last quarter. Arkadios Wealth Advisors purchased a new position in Teladoc Health during the 4th quarter worth $115,000. Finally, Smith Anglin Financial LLC purchased a new position in Teladoc Health during the 4th quarter worth $108,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Up 5.2 %

NYSE TDOC traded up $0.50 on Wednesday, hitting $10.00. 3,108,837 shares of the stock were exchanged, compared to its average volume of 4,023,879. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $21.74. The company has a market cap of $1.72 billion, a PE ratio of -1.73 and a beta of 1.01. The company has a 50-day moving average price of $9.96 and a 200-day moving average price of $9.02.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. Sell-side analysts anticipate that Teladoc Health will post -1.16 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Piper Sandler restated an “overweight” rating and issued a $13.00 target price (up from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. TD Cowen dropped their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday, October 31st. Barclays increased their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. The Goldman Sachs Group assumed coverage on shares of Teladoc Health in a research note on Friday, November 15th. They set a “buy” rating and a $14.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Fourteen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $12.24.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.